Abstract

Introduction: The standard corneal crosslinking (S- CXL) technique requires corneal epithelial removal, thus increasing the risk of postoperative complications. Newer technique like iontophoresis-assisted corneal crosslinking (I-CXL) with comparable efficacy as S-CXL but without the increased risk of complications associated with corneal epithelium removal is used. However, being a comparatively newer technique, the safety and efficacy of I-CXL have not been fully explored. Case Description: Here, we present a case of a 28-year-old woman who presented with infective keratitis in one eye after uneventful bilateral I-CXL for keratoconus. Two days after the procedure, the patient presented with decreased vision and pain in the right eye. Clinical examination revealed ciliary injection and central corneal rounded infiltrates measuring 3.0 mm × 3.0 mm with an overlying epithelial defect. Microbiological studies revealed negative results. Based on clinical examination, the patient was managed successfully with fortified topical antibiotics. Conclusion: To the best of our knowledge, we report the first documented case of unilateral infective keratitis following bilateral I-CXL. Ophthalmologists should monitor the possible complications post-I-CXL as it might not be as safe as we expect.

Highlights

  • ConclusionTo the best of our knowledge, we report the first documented case of unilateral infective keratitis following bilateral iontophoresis-assisted CXL (I-CXL)

  • The standard corneal crosslinking (S- CXL) technique requires corneal epithelial removal, increasing the risk of postoperative complications

  • To the best of our knowledge, we report the first documented case of unilateral infective keratitis following bilateral iontophoresis-assisted CXL (I-CXL)

Read more

Summary

Conclusion

To the best of our knowledge, we report the first documented case of unilateral infective keratitis following bilateral I-CXL.

INTRODUCTION
CASE REPORT
Findings
DISCUSSION
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call